Special issues in fertility preservation for gynecologic malignancies

Federica Tomao, Fedro Peccatori, Lino del Pup, Dorella Franchi, Vanna Zanagnolo, Pierluigi Benedetti Panici, Nicoletta Colombo

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Gynecologic malignancies account for 1,09 million new cancer cases worldwide consisting of about 12% of tumors affecting female population. About 10% of all female cancer survivors are younger than 40 years of age. Since cancers affecting female genital organs are usually treated by radical surgery, chemotherapy or chemoradiation approaches that induce permanent damage of reproductive functions, the development of strategies for fertility preservation represent one of the most important goals for gynecologic oncology. In this scenario, the newly defined oncofertility discipline acquires increasing interest, offering patients maximal chances to make an adequate decision about future fertility, based on their oncologic diagnosis and prognosis. However, the majority of physicians do not pay particular attention to these issues, even if impressive progresses have been made in this field in the last decades. Possibly, it is due to the lack of strong evidences from clinical trials without an adequate number of cases to establish safety and efficacy of these procedures. In this review we will discuss the most recently debated options for fertility preservation in gynecologic oncology, highlighting issues and controversies related to oncofertility.

Original languageEnglish
Pages (from-to)206-219
Number of pages14
JournalCritical Reviews in Oncology/Hematology
Volume97
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Fertility Preservation
Neoplasms
Female Genitalia
Fertility
Survivors
Clinical Trials
Physicians
Safety
Drug Therapy
Population

Keywords

  • Borderline ovarian tumor
  • Cervical cancer
  • Endometrial cancer
  • Fertility sparing
  • Malignant ovarian germ cell tumors
  • Ovarian cancer
  • Uterus transplantation

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Geriatrics and Gerontology

Cite this

Special issues in fertility preservation for gynecologic malignancies. / Tomao, Federica; Peccatori, Fedro; Pup, Lino del; Franchi, Dorella; Zanagnolo, Vanna; Panici, Pierluigi Benedetti; Colombo, Nicoletta.

In: Critical Reviews in Oncology/Hematology, Vol. 97, 01.01.2016, p. 206-219.

Research output: Contribution to journalArticle

@article{5cd037d1dcfb4cc98c53c13e6bc0fa9c,
title = "Special issues in fertility preservation for gynecologic malignancies",
abstract = "Gynecologic malignancies account for 1,09 million new cancer cases worldwide consisting of about 12{\%} of tumors affecting female population. About 10{\%} of all female cancer survivors are younger than 40 years of age. Since cancers affecting female genital organs are usually treated by radical surgery, chemotherapy or chemoradiation approaches that induce permanent damage of reproductive functions, the development of strategies for fertility preservation represent one of the most important goals for gynecologic oncology. In this scenario, the newly defined oncofertility discipline acquires increasing interest, offering patients maximal chances to make an adequate decision about future fertility, based on their oncologic diagnosis and prognosis. However, the majority of physicians do not pay particular attention to these issues, even if impressive progresses have been made in this field in the last decades. Possibly, it is due to the lack of strong evidences from clinical trials without an adequate number of cases to establish safety and efficacy of these procedures. In this review we will discuss the most recently debated options for fertility preservation in gynecologic oncology, highlighting issues and controversies related to oncofertility.",
keywords = "Borderline ovarian tumor, Cervical cancer, Endometrial cancer, Fertility sparing, Malignant ovarian germ cell tumors, Ovarian cancer, Uterus transplantation",
author = "Federica Tomao and Fedro Peccatori and Pup, {Lino del} and Dorella Franchi and Vanna Zanagnolo and Panici, {Pierluigi Benedetti} and Nicoletta Colombo",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.critrevonc.2015.08.024",
language = "English",
volume = "97",
pages = "206--219",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Special issues in fertility preservation for gynecologic malignancies

AU - Tomao, Federica

AU - Peccatori, Fedro

AU - Pup, Lino del

AU - Franchi, Dorella

AU - Zanagnolo, Vanna

AU - Panici, Pierluigi Benedetti

AU - Colombo, Nicoletta

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Gynecologic malignancies account for 1,09 million new cancer cases worldwide consisting of about 12% of tumors affecting female population. About 10% of all female cancer survivors are younger than 40 years of age. Since cancers affecting female genital organs are usually treated by radical surgery, chemotherapy or chemoradiation approaches that induce permanent damage of reproductive functions, the development of strategies for fertility preservation represent one of the most important goals for gynecologic oncology. In this scenario, the newly defined oncofertility discipline acquires increasing interest, offering patients maximal chances to make an adequate decision about future fertility, based on their oncologic diagnosis and prognosis. However, the majority of physicians do not pay particular attention to these issues, even if impressive progresses have been made in this field in the last decades. Possibly, it is due to the lack of strong evidences from clinical trials without an adequate number of cases to establish safety and efficacy of these procedures. In this review we will discuss the most recently debated options for fertility preservation in gynecologic oncology, highlighting issues and controversies related to oncofertility.

AB - Gynecologic malignancies account for 1,09 million new cancer cases worldwide consisting of about 12% of tumors affecting female population. About 10% of all female cancer survivors are younger than 40 years of age. Since cancers affecting female genital organs are usually treated by radical surgery, chemotherapy or chemoradiation approaches that induce permanent damage of reproductive functions, the development of strategies for fertility preservation represent one of the most important goals for gynecologic oncology. In this scenario, the newly defined oncofertility discipline acquires increasing interest, offering patients maximal chances to make an adequate decision about future fertility, based on their oncologic diagnosis and prognosis. However, the majority of physicians do not pay particular attention to these issues, even if impressive progresses have been made in this field in the last decades. Possibly, it is due to the lack of strong evidences from clinical trials without an adequate number of cases to establish safety and efficacy of these procedures. In this review we will discuss the most recently debated options for fertility preservation in gynecologic oncology, highlighting issues and controversies related to oncofertility.

KW - Borderline ovarian tumor

KW - Cervical cancer

KW - Endometrial cancer

KW - Fertility sparing

KW - Malignant ovarian germ cell tumors

KW - Ovarian cancer

KW - Uterus transplantation

UR - http://www.scopus.com/inward/record.url?scp=84952638386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952638386&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2015.08.024

DO - 10.1016/j.critrevonc.2015.08.024

M3 - Article

VL - 97

SP - 206

EP - 219

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -